299 related articles for article (PubMed ID: 10871098)
1. Use of the local lymph node assay for the estimation of relative contact allergenic potency.
Basketter DA; Balikie L; Dearman RJ; Kimber I; Ryan CA; Gerberick GF; Harvey P; Evans P; White IR; Rycroft RJ
Contact Dermatitis; 2000 Jun; 42(6):344-8. PubMed ID: 10871098
[TBL] [Abstract][Full Text] [Related]
2. Contact allergenic potency: correlation of human and local lymph node assay data.
Gerberick GF; Robinson MK; Ryan CA; Dearman RJ; Kimber I; Basketter DA; Wright Z; Marks JG
Am J Contact Dermat; 2001 Sep; 12(3):156-61. PubMed ID: 11526521
[TBL] [Abstract][Full Text] [Related]
3. The impact of vehicle on the relative potency of skin-sensitizing chemicals in the local lymph node assay.
Jowsey IR; Clapp CJ; Safford B; Gibbons BT; Basketter DA
Cutan Ocul Toxicol; 2008; 27(2):67-75. PubMed ID: 18568891
[TBL] [Abstract][Full Text] [Related]
4. Estimation of relative skin sensitizing potency using the local lymph node assay: a comparison of formaldehyde with glutaraldehyde.
Hilton J; Dearman RJ; Harvey P; Evans P; Basketter DA; Kimber I
Am J Contact Dermat; 1998 Mar; 9(1):29-33. PubMed ID: 9471984
[TBL] [Abstract][Full Text] [Related]
5. Human potency predictions for aldehydes using the local lymph node assay.
Basketter DA; Wright ZM; Warbrick EV; Dearman RJ; Kimber I; Ryan CA; Gerberick GF; White IR
Contact Dermatitis; 2001 Aug; 45(2):89-94. PubMed ID: 11553118
[TBL] [Abstract][Full Text] [Related]
6. Skin sensitization testing in potency and risk assessment.
Kimber I; Basketter DA; Berthold K; Butler M; Garrigue JL; Lea L; Newsome C; Roggeband R; Steiling W; Stropp G; Waterman S; Wiemann C
Toxicol Sci; 2001 Feb; 59(2):198-208. PubMed ID: 11158712
[TBL] [Abstract][Full Text] [Related]
7. Influence of application vehicle on skin sensitization to methylchloroisothiazolinone/methylisothiazolinone: an analysis using the local lymph node assay.
Warbrick EV; Dearman RJ; Basketter DA; Kimber I
Contact Dermatitis; 1999 Dec; 41(6):325-9. PubMed ID: 10617213
[TBL] [Abstract][Full Text] [Related]
8. Novel approach for classifying chemicals according to skin sensitizing potency by non-radioisotopic modification of the local lymph node assay.
Takeyoshi M; Iida K; Shiraishi K; Hoshuyama S
J Appl Toxicol; 2005; 25(2):129-34. PubMed ID: 15744759
[TBL] [Abstract][Full Text] [Related]
9. Predictive identification of human skin sensitization thresholds.
Basketter DA; Clapp C; Jefferies D; Safford B; Ryan CA; Gerberick F; Dearman RJ; Kimber I
Contact Dermatitis; 2005 Nov; 53(5):260-7. PubMed ID: 16283904
[TBL] [Abstract][Full Text] [Related]
10. Reproducible prediction of contact allergenic potency using the local lymph node assay.
Basketter DA; Cadby P
Contact Dermatitis; 2004 Jan; 50(1):15-7. PubMed ID: 15059097
[TBL] [Abstract][Full Text] [Related]
11. The local lymph node assay and the assessment of relative potency: status of validation.
Basketter DA; Gerberick F; Kimber I
Contact Dermatitis; 2007 Aug; 57(2):70-5. PubMed ID: 17627643
[TBL] [Abstract][Full Text] [Related]
12. The local lymph node assay: past, present and future.
Kimber I; Dearman RJ; Basketter DA; Ryan CA; Gerberick GF
Contact Dermatitis; 2002 Dec; 47(6):315-28. PubMed ID: 12581276
[TBL] [Abstract][Full Text] [Related]
13. A comparison of statistical approaches to the derivation of EC3 values from local lymph node assay dose responses.
Basketter DA; Lea LJ; Dickens A; Briggs D; Pate I; Dearman RJ; Kimber I
J Appl Toxicol; 1999; 19(4):261-6. PubMed ID: 10439340
[TBL] [Abstract][Full Text] [Related]
14. Proposal for a risk assessment methodology for skin sensitization based on sensitization potency data.
Griem P; Goebel C; Scheffler H
Regul Toxicol Pharmacol; 2003 Dec; 38(3):269-90. PubMed ID: 14623479
[TBL] [Abstract][Full Text] [Related]
15. Skin sensitisation, vehicle effects and the local lymph node assay.
Basketter DA; Gerberick GF; Kimber I
Food Chem Toxicol; 2001 Jun; 39(6):621-7. PubMed ID: 11346493
[TBL] [Abstract][Full Text] [Related]
16. Local lymph node assay responses to paraphenylenediamine: intra- and inter-laboratory evaluations.
Warbrick EV; Dearman RJ; Lea LJ; Basketter DA; Kimber I
J Appl Toxicol; 1999; 19(4):255-60. PubMed ID: 10439339
[TBL] [Abstract][Full Text] [Related]
17. The impact of vehicle on assessment of relative skin sensitization potency of 1,4-dihydroquinone in the local lymph node assay.
Lea LJ; Warbrick EV; Dearman RJ; Kimber I; Basketter DA
Am J Contact Dermat; 1999 Dec; 10(4):213-8. PubMed ID: 10594297
[TBL] [Abstract][Full Text] [Related]
18. Potency values from the local lymph node assay: application to classification, labelling and risk assessment.
Loveless SE; Api AM; Crevel RW; Debruyne E; Gamer A; Jowsey IR; Kern P; Kimber I; Lea L; Lloyd P; Mehmood Z; Steiling W; Veenstra G; Woolhiser M; Hennes C
Regul Toxicol Pharmacol; 2010 Feb; 56(1):54-66. PubMed ID: 19733604
[TBL] [Abstract][Full Text] [Related]
19. Correlation between experimental human and murine skin sensitization induction thresholds.
Api AM; Basketter D; Lalko J
Cutan Ocul Toxicol; 2015; 34(4):298-302. PubMed ID: 25430073
[TBL] [Abstract][Full Text] [Related]
20. Potency and risk assessment of a skin-sensitizing disperse dye using the local lymph node assay.
Betts CJ; Dearman RJ; Kimber I; Maibach HI
Contact Dermatitis; 2005 May; 52(5):268-72. PubMed ID: 15899000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
